Presented positive data from Phase 1 clinical trials with ARV-102 in healthy volunteers and patients with Parkinson’s disease –– Presented ...

The Howard League explains how the Government's earned progression plan could inadvertently result in increasing the numbers ...

Join us as we dive into the incredible journey of the Hulk within the renowned Lego Marvel video game series. From his iconic ...

Artificial intelligence (AI) is transforming healthcare and life sciences, offering the potential to accelerate drug discovery, enhance diagnostics, and improve patient outcomes. Recent industry ...

Data update from vopimetostat (TNG462) showed 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months– – Combination ...

The online casino industry has long been synonymous with high risk, high reward, and fierce competition. Over the last decade ...

London, England / / October 29, 2025 / DigitalBiz Limited Key Takeaways AI models prioritize content structure and clarity over keyword density – Unlike traditional SEO, LLM optimization focuses on ...

There is a principle in economics that ought to be better known: any well-intentioned policy will backfire on those it’s ...

A study has found a previously known cancer-related drug can also help slow down the symptoms of Parkinson's disease, but ...

A study using wearable scanning technology has revealed how brain function differs in people with multiple sclerosis (MS). It ...

That level of activity slows cognitive decline by 3 years, on average, the results show. And in similar individuals who walk further, taking 5,000 to 7,500 steps per day, decline slows by an average ...

Imatinib (Gleevec) showed durable efficacy in advanced gastrointestinal stromal tumors (GIST), with complete response (CR) or ...